Luigi Mangione's legal defense fund hits $1 million in donations
Hinge Health says revenue increased 50% in first quarter — still no price range for IPO
Hinge Health says revenue increased 50% in first quarter — still no price range for IPO
Hims & Hers gives weak outlook but says more collaborations are coming
Trump signs order to boost domestic drug manufacturing as pharma tariffs loom
Function Health buys Ezra, launches full-body scan for a third of the price
Hims & Hers brings former Amazon executive into C-suite
From 'Cockroach Award' to the Big Board: Hinge Health's unlikely path to IPO
